Patents Assigned to Fondazione Centro San Raffaele Del Monte Tabor
  • Use of oversulfated polysaccharides as inhibitors of HIV
    Patent number: 7268122
    Abstract: The present invention relates to the use of N,O oversulfated K5 derivatives having a degree of sulfation higher than 3.2 or of their pharmaceutically acceptable salts for the preparation of pharmaceutical compositions for treating the infection and the consequent HIV/ADS disease.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: September 11, 2007
    Assignees: Fondazione Centro San Raffaele Del Monte Tabor
    Inventors: Giorgio Zoppetti, Pasqua Anna Oreste, Guido Poli, Elisa Vicenzi
  • RANTES mutants and therapeutic applications thereof
    Patent number: 7164000
    Abstract: RANTES mutants characterised by the substitution or addition of amino acids at the N-terminal of RANTES wild-type sequence and in the N-loop and/or 40's loop regions of RANTES wild-type sequence, and their use as anti-HIV, anti-allergic or anti-inflammatory agents.
    Type: Grant
    Filed: March 28, 2003
    Date of Patent: January 16, 2007
    Assignee: Fondazione Centro San Raffaele Del Monte Tabor
    Inventors: Paolo Lusso, Simona Polo
  • Modified cytokines for use in cancer therapy
    Patent number: 7150869
    Abstract: Cytokine derivatives capable of homing the tumoral vessels and the antigen presenting cells and the use thereof as antitumoral agents.
    Type: Grant
    Filed: August 15, 2002
    Date of Patent: December 19, 2006
    Assignee: Fondazione Centro San Raffaele del Monte Tabor
    Inventor: Angelo Corti
  • Modified cytokines for use in cancer therapy
    Patent number: 7109303
    Abstract: Cytokine derivatives capable of homing the tumoral vessels and the antigen presenting cells and the use thereof as antitumoral agents ate disclosed.
    Type: Grant
    Filed: April 30, 2003
    Date of Patent: September 19, 2006
    Assignee: Fondazione Centro San Raffaele Del Monte Tabor
    Inventor: Angelo Corti
  • Method for the quantitative detection of nucleic acids
    Patent number: 7029843
    Abstract: Provided herein is a method for the quantitative detection of nucleic acids based on the use of a calibrator, suitable primers and probes, and a nucleic acid polymerase with 5?-3? nuclease activity.
    Type: Grant
    Filed: November 17, 1999
    Date of Patent: April 18, 2006
    Assignee: Fondazione Centro San Raffaele Del Monte Tabor
    Inventors: Giuseppe Locatelli, Paolo Lusso, Mauro Malnati, Francesca Salvatori, Gabriella Scarlatti
  • RANTES derived peptides with anti-HIV activity
    Patent number: 6709649
    Abstract: Peptides having 12 to 30 amino acids with sequence homologous or corresponding to the sequence 1o-34 of RANTES having inhibitory activity against the human immunodeficiency virus (HIV) as well as anti-allergic and antiinflamatory activity.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: March 23, 2004
    Assignees: Fondazione Centro San Raffaele Del Monte Tabor, PRIMM S.r.l.
    Inventors: Paolo Lusso, Vincenzo Pavone
  • Modified cytokines for use in cancer therapy
    Publication number: 20040018171
    Abstract: Cytokine derivatives capable of homing the tumoral vessels and the antigen presenting cells and the use thereof as antitumoral agents.
    Type: Application
    Filed: April 30, 2003
    Publication date: January 29, 2004
    Applicant: FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
    Inventor: Angelo Corti
  • Modified cytokines for use in cancer therapy
    Publication number: 20030157055
    Abstract: Cytokine derivatives capable of homing the tumoral vessels and the antigen presenting cells and the use thereof as antitumoral agents.
    Type: Application
    Filed: August 15, 2002
    Publication date: August 21, 2003
    Applicant: FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
    Inventor: Angelo Corti
  • Modified cytokines for use in cancer therapy
    Publication number: 20030157056
    Abstract: Cytokine derivatives capable of homing the tumoral vessels and the antigen presenting cells and the use thereof as antitumoral agents.
    Type: Application
    Filed: November 5, 2002
    Publication date: August 21, 2003
    Applicant: FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
    Inventor: Angelo Corti
  • Rantes mutants and therapeutic applications thereof
    Patent number: 6608177
    Abstract: RANTES mutants characterized by the substitution or addition of amino acids at the N-terminal or RANTES wild-type sequence and in the N loop and/or 40′ loop regions of RNATES wild-type sequence, and their use as anti-HIV, anti-allergic or anti-inflammatory agents.
    Type: Grant
    Filed: June 9, 2000
    Date of Patent: August 19, 2003
    Assignee: Fondazione Centro San Raffaele del Monte Tabor
    Inventors: Paolo Lusso, Simona Polo
  • UPAR mimicking peptide
    Patent number: 6462170
    Abstract: Peptides comprising the SRSRY sequence (SEQ ID NO: 7) derived from the uPAR (urokinase receptor) are endowed with chemotactic activity, making them useful for preventing or activating the migration of cells in a mammal. More particularly, the peptides of the invention are useful for the treatment of cancer, autoimmune diseases, and/or hyperinflammatory diseases and for stimulating wound healing.
    Type: Grant
    Filed: October 20, 1999
    Date of Patent: October 8, 2002
    Assignees: Fondazione Centro San Raffaele del Monte Tabor, Universita Degli Studi di Milano
    Inventors: Francesco Blasi, Francesca Fazioli, Massimo Resnati, Nicolai Sidenius